510(K) CLEARANCES 75 ▼9RECALLS POSTED 26 ▼13CLASS I 2 ▼4PMA DECISIONS 54 ▲7WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K921908Substantially Equivalent

Novolinpen Dial-a-Dose Insulin Delivery Device

Novo Nordisk Pharmaceuticals, Inc., Princeton NJ / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K921908 is the FDA 510(k) clearance record for NOVOLINPEN DIAL-A-DOSE INSULIN DELIVERY DEVICE, a class II device, cleared for Novo Nordisk Pharmaceuticals, Inc. on under FDA product code FMF (Syringe, Piston). FDA records list 2 510(k) clearances for Novo Nordisk Pharmaceuticals, Inc., from to . As of , FDA records show no recalls naming K921908.

Clearance record

Decision date
Received
(432 days to decision)
Product code
FMF Syringe, Piston
Regulation
21 CFR 880.5860
Device class
Class II
Review panel
General Hospital
Applicant
Novo Nordisk Pharmaceuticals, Inc. 100 Overlook Ctr., Princeton NJ
510(k) summary
Statement
Third party review
No

Clearances, product code FMF

Trailing 12 months
14 clearances under product code FMF in the twelve months to October 2026, December 2025 the highest month at 4.
Show the numbers
Monthly 510(k) clearances under FDA product code FMF, trailing twelve months
MonthClearances
November 20251
December 20254
January 20260
February 20261
March 20260
April 20261
May 20261
June 20262
July 20261
August 20263
September 20260
October 20260